Form 4: Omada Health Exec Sells Shares Under 10b5-1 Plan

Omada Health's Chief Financial Officer, Steven L. Cook, reported the sale of Omada Health common stock under a pre-arranged trading plan.

Summary

• Steven L. Cook, Chief Financial Officer of Omada Health, Inc., executed transactions involving the sale of company common stock.
• These sales occurred on June 26, 2026, and June 29, 2026.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on March 14, 2026.
• On June 26, 2026, 33,000 shares were sold at a weighted average price of $19.8924.
• On June 29, 2026, an additional 17,950 shares were sold at a price of $21.0678.
• Following these transactions, Mr. Cook beneficially owns 115,409 shares of Omada Health common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to insider selling, although the use of a 10b5-1 plan mitigates some of the negative implications.

Negatives

• Company insider selling stock, which could be perceived negatively by the market.
• The sales represent a reduction in direct beneficial ownership by a key executive.

Risks

• Potential for negative market perception due to insider selling.
• The sales are part of a pre-arranged plan, which may indicate the executive's expectation of future stock price performance or a need for liquidity.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on past transactions.

Management Comments

• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a 10b5-1 plan is a common strategy for executives to diversify their holdings or manage personal finances without being perceived as trading on material non-public information. The specific prices and volume of shares sold will be closely watched by investors for any indication of management's sentiment towards the company's valuation.

Stakeholder Impact

• Shareholders: May interpret insider sales as a sign of reduced confidence or a need for liquidity, potentially impacting share price.
• Employees: May view insider sales with concern, especially if they hold company stock options or shares.
• Management: The transactions are executed under a pre-arranged plan, indicating adherence to governance protocols for insider trading.

Next Steps

• Continued monitoring of Steven L. Cook's beneficial ownership and any future transactions.
• Observation of market reaction to these insider sales.

Key Dates

Recommendation

The filing reports routine insider transactions under a 10b5-1 plan, which is a standard practice. While insider selling can be a negative signal, the structured nature of the sales suggests it's not necessarily a reflection of a negative outlook on the company's fundamentals. Therefore, a 'hold' recommendation is appropriate pending further company performance data.

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Steven L. Cook, Chief Financial Officer, Beneficial Ownership